Sanofi cuts research staffers in Boston as reorganization looms: report

Sanofi ($SNY) is cutting more than 30 lab workers in its Boston hub, according to the Boston Globe. Citing staffers, the report notes that the jobs are being axed in groups that were part of the Genzyme organization acquired by Sanofi. The layoffs may presage more cuts as Sanofi is rumored to be readying a company-wide reorganization, which includes cutting hundreds of unfilled job openings in France. Report

Suggested Articles

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.

The top-line readout appears to justify the risk the partners took when they advanced the drug despite missing the primary endpoint in phase 2.